Journal of Biological Chemistry · 2010 · 45 citations · 52 references
Life SciencesBiochemistryMolecular BiologyCell SignalingGlycobiologySignal TransductionG Protein-coupled Receptor SignalingGlycan StructureReceptor PharmacologyReceptor PhysiologyReceptor RegulationReceptor-mediated SignalingAdrenergic Receptor SignalingBiotinylation Of Cell-surface MoleculesCell Surface GlycoproteinsG Protein-coupled Receptor RegulationG Protein-coupled SignalingMucin Domain GlycosylationMucin-type O-glycosylationReceptors
The β1-adrenergic receptor (β1AR) is the predominant βAR in the heart, mediating the catecholamine-stimulated increase in cardiac rate and force of contraction. Regulation of this important G protein-coupled receptor is nevertheless poorly understood. We describe here the biosynthetic profile of the human β1AR and reveal novel features relevant to its regulation using an inducible heterologous expression system in HEK293i cells. Metabolic pulse-chase labeling and cell surface biotinylation assays showed that the synthesized receptors are efficiently and rapidly transported to the cell surface. The N terminus of the mature receptor is extensively modified by sialylated mucin-type O-glycosylation in addition to one N-glycan attached to Asn15. Furthermore, the N terminus was found to be subject to limited proteolysis, resulting in two membrane-bound C-terminal fragments. N-terminal sequencing of the fragments identified two cleavage sites between Arg31 and Leu32 and Pro52 and Leu53, which were confirmed by cleavage site and truncation mutants. Metalloproteinase inhibitors were able to inhibit the cleavage, suggesting that it is mediated by a matrix metalloproteinase or a disintegrin and metalloproteinase (ADAM) family member. Most importantly, the N-terminal cleavage was found to occur not only in vitro but also in vivo. Receptor activation mediated by the βAR agonist isoproterenol enhanced the cleavage in a concentration- and time-dependent manner, and it was also enhanced by direct stimulation of protein kinase C and adenylyl cyclase. Mutation of the Arg31–Leu32 cleavage site stabilized the mature receptor. We hypothesize that the N-terminal cleavage represents a novel regulatory mechanism of cell surface β1ARs. The β1-adrenergic receptor (β1AR) is the predominant βAR in the heart, mediating the catecholamine-stimulated increase in cardiac rate and force of contraction. Regulation of this important G protein-coupled receptor is nevertheless poorly understood. We describe here the biosynthetic profile of the human β1AR and reveal novel features relevant to its regulation using an inducible heterologous expression system in HEK293i cells. Metabolic pulse-chase labeling and cell surface biotinylation assays showed that the synthesized receptors are efficiently and rapidly transported to the cell surface. The N terminus of the mature receptor is extensively modified by sialylated mucin-type O-glycosylation in addition to one N-glycan attached to Asn15. Furthermore, the N terminus was found to be subject to limited proteolysis, resulting in two membrane-bound C-terminal fragments. N-terminal sequencing of the fragments identified two cleavage sites between Arg31 and Leu32 and Pro52 and Leu53, which were confirmed by cleavage site and truncation mutants. Metalloproteinase inhibitors were able to inhibit the cleavage, suggesting that it is mediated by a matrix metalloproteinase or a disintegrin and metalloproteinase (ADAM) family member. Most importantly, the N-terminal cleavage was found to occur not only in vitro but also in vivo. Receptor activation mediated by the βAR agonist isoproterenol enhanced the cleavage in a concentration- and time-dependent manner, and it was also enhanced by direct stimulation of protein kinase C and adenylyl cyclase. Mutation of the Arg31–Leu32 cleavage site stabilized the mature receptor. We hypothesize that the N-terminal cleavage represents a novel regulatory mechanism of cell surface β1ARs. IntroductionThe β1-adrenergic receptor (β1AR) 3The abbreviations used are: β1ARβ1-adrenergic receptorhhumanADAMa disintegrin and metalloproteinaseCGP-207121-[2-((3-carbamoyl-4-hydroxy)phenoxy)ethylamino]-3-[4-(1-methyl-4-trifluoromethyl-2-imidazolyl)phenoxy]-2-propanol dihydrochlorideDDMn-dodecyl-β-d-maltosideEndo Hendo-β-N-acetylglucosaminidase HERendoplasmic reticulumGPCRG protein-coupled receptorISOisoproterenolNHSN-hydroxysuccinimidePMAphorbol 12-myristate 13-acetatePNGase Fpeptide-N-glycosidase FBFAbrefeldin A. is one of the three βAR subtypes that are activated by the endogenous catecholamines adrenaline and noradrenaline (1Bylund D.B. Eikenberg D.C. Hieble J.P. Langer S.Z. Lefkowitz R.J. Minneman K.P. Molinoff P.B. Ruffolo Jr., R.R. Trendelenburg U. Pharmacol. Rev. 1994; 46: 121-136PubMed Google Scholar). These receptors belong to the G protein-coupled receptor (GPCR) family, one of the largest membrane protein families involved in cellular signaling (2Fredriksson R. Lagerström M.C. Lundin L.G. Schiöth H.B. Mol. Pharmacol. 2003; 63: 1256-1272Crossref PubMed Scopus (2118) Google Scholar, 3Lagerström M.C. Schiöth H.B. Nat. Rev. Drug Discov. 2008; 7: 339-357Crossref PubMed Scopus (1099) Google Scholar). The β1AR is the predominant βAR subtype in the heart, mediating the increase in cardiac rate and force of contraction (4Rockman H.A. Koch W.J. Lefkowitz R.J. Nature. 2002; 415: 206-212Crossref PubMed Scopus (778) Google Scholar, 5Brodde O.E. Bruck H. Leineweber K. J. Pharmacol. Sci. 2006; 100: 323-337Crossref PubMed Scopus (196) Google Scholar). This makes it the most important target receptor for the β-blockers that are used to treat common cardiac diseases such as chronic heart failure, coronary artery disease, hypertension, and arrhythmias. The mechanisms that regulate human β1AR (hβ1AR) are therefore of considerable interest.The hβ2AR is one of the most extensively studied GPCRs, but much less is known about hβ1AR. The suggestion that it may be more resistant to agonist-mediated desensitization (6Rousseau G. Nantel F. Bouvier M. Mol. Pharmacol. 1996; 49: 752-760PubMed Google Scholar), internalization (7Suzuki T. Nguyen C.T. Nantel F. Bonin H. Valiquette M. Frielle T. Bouvier M. Mol. Pharmacol. 1992; 41: 542-548PubMed Google Scholar, 8Green S.A. Liggett S.B. J. Biol. Chem. 1994; 269: 26215-26219Abstract Full Text PDF PubMed Google Scholar, 9Shiina T. Kawasaki A. Nagao T. Kurose H. J. Biol. Chem. 2000; 275: 29082-29090Abstract Full Text Full Text PDF PubMed Scopus (79) Google Scholar, 10McLean A.J. Milligan G. Br. J. Pharmacol. 2000; 130: 1825-1832Crossref PubMed Scopus (69) Google Scholar, 11Xiang Y. Devic E. Kobilka B. J. Biol. Chem. 2002; 277: 33783-33790Abstract Full Text Full Text PDF PubMed Scopus (89) Google Scholar, 12Liang W. Curran P.K. Hoang Q. Moreland R.T. Fishman P.H. J. Cell Sci. 2004; 117: 723-734Crossref PubMed Scopus (30) Google Scholar), and down-regulation (7Suzuki T. Nguyen C.T. Nantel F. Bonin H. Valiquette M. Frielle T. Bouvier M. Mol. Pharmacol. 1992; 41: 542-548PubMed Google Scholar, 10McLean A.J. Milligan G. Br. J. Pharmacol. 2000; 130: 1825-1832Crossref PubMed Scopus (69) Google Scholar, 13Dunigan C.D. Hoang Q. Curran P.K. Fishman P.H. Biochemistry. 2002; 41: 8019-8030Crossref PubMed Scopus (24) Google Scholar, 14Liang W. Austin S. Hoang Q. Fishman P.H. J. Biol. Chem. 2003; 278: 39773-39781Abstract Full Text Full Text PDF PubMed Scopus (28) Google Scholar) could indicate that the two receptors are regulated by distinct mechanisms. Their ligand-binding sites are well conserved, but the overall homology of the two βARs is only 54% (15Frielle T. Collins S. Daniel K.W. Caron M.G. Lefkowitz R.J. Kobilka B.K. Proc. Natl. Acad. Sci. U.S.A. 1987; 84: 7920-7924Crossref PubMed Scopus (512) Google Scholar). The most diverse regions are the intervening loops that connect the transmembrane domains, the extracellular N terminus and the intracellular C terminus. The third intracellular loops and the C-terminal tails of β1AR and β2AR have been implicated in the mediation of interactions with distinct intracellular proteins, including a number of PSD-95/Discs-large/ZO-1-homology (PDZ) domain-containing proteins that have divergent roles in receptor signaling and trafficking (reviewed in Refs. 16Hall R.A. Semin. Cell Dev. Biol. 2004; 15: 281-288Crossref PubMed Scopus (55) Google Scholar, 17Marchese A. Paing M.M. Temple B.R. Trejo J. Annu. Rev. Pharmacol. Toxicol. 2008; 48: 601-629Crossref PubMed Scopus (350) Google Scholar). In contrast, the extracellular domains of the two βARs have aroused only limited interest and have been thought to have a negligible role in receptor activation and regulation. This is probably related to the relatively short length of the N termini and the absence of noticeable functional domains with conserved motifs as opposed to GPCRs, e.g. in the adhesion receptor family (2Fredriksson R. Lagerström M.C. Lundin L.G. Schiöth H.B. Mol. Pharmacol. 2003; 63: 1256-1272Crossref PubMed Scopus (2118) Google Scholar, 3Lagerström M.C. Schiöth H.B. Nat. Rev. Drug Discov. 2008; 7: 339-357Crossref PubMed Scopus (1099) Google Scholar). Recent evidence nevertheless suggests that the extracellular βAR domains may have a more important role than had been anticipated. For example, the crystal structure of turkey β1AR revealed that the second extracellular loop participates in ligand binding, defining the entrance to the ligand binding pocket within the 7-transmembrane domain bundle (18Warne T. Serrano-Vega M.J. Baker J.G. Moukhametzianov R. Edwards P.C. Henderson R. Leslie A.G. Tate C.G. Schertler G.F. Nature. 2008; 454: 486-491Crossref PubMed Scopus (1227) Google Scholar). On the other hand, ligand binding was found to lead to conformational changes in the β2AR N terminus and extracellular loops, as was revealed by conformation-specific antibodies and NMR spectroscopy, respectively (19Gupta A. Décaillot F.M. Gomes I. Tkalych O. Heimann A.S. Ferro E.S. Devi L.A. J. Biol. Chem. 2007; 282: 5116-5124Abstract Full Text Full Text PDF PubMed Scopus (84) Google Scholar, 20Bokoch M.P. Zou Y. Rasmussen S.G. Liu C.W. Nygaard R. Rosenbaum D.M. Fung J.J. Choi H.J. Thian F.S. Kobilka T.S. Puglisi J.D. Weis W.I. Pardo L. Prosser R.S. Mueller L. Kobilka B.K. Nature. 2010; 463: 108-112Crossref PubMed Scopus (397) Google Scholar).To initiate investigations into the mechanisms that regulate hβ1AR, we set out to characterize the specific steps that take place during the biogenesis of this GPCR. We demonstrate here that the receptor N terminus is extensively modified by mucin-type O-glycosylation during the rapid transport to the cell surface in addition to one N-glycan. Furthermore, the N terminus of the mature receptor with fully processed oligosaccharides was found to be subject to proteolytic cleavage by metalloproteinases, a cleavage that occurred both in vitro and in vivo. This cleavage was enhanced by agonist-mediated receptor activation and by direct activation of protein kinase C and adenylyl cyclase. On the other hand, mutation of the primary cleavage site was found to lead to stabilization of mature receptors. These results allow us to hypothesize that the N-terminal cleavage represents a novel way of controlling the number of functionally active cell surface β1ARs.DISCUSSIONThe present description of the biosynthetic profile of the hβ1AR in a heterologous expression system distinct features of the of the receptor that are relevant to its regulation. We that the hβ1AR is a that is efficiently the cell surface and is extensively during transport to the N-glycan is to the conserved and mucin-type sialylated are to the N-terminal the N terminus to be to cleavage by a metalloproteinase of the matrix metalloproteinase or the resulting in the of two membrane-bound C-terminal receptor fragments. The cleavage was found to take place in importantly, was enhanced agonist-mediated receptor activation or direct stimulation of protein kinase C and adenylyl cyclase. Furthermore, of the cleavage by mutation of the cleavage site of the receptor was found to the mature receptors. These results that the extracellular N terminus of the β1AR a distinct functional role in receptor regulation. This N-terminal cleavage may be a way of the number of the cell cellular to βAR N-terminal cleavage of the β1AR was for the turkey receptor in R. M. Biochemistry. PubMed Scopus Google Scholar). including and have also been to β1AR in endogenous Caron M.G. Lefkowitz R.J. J. Biol. Chem. Full Text PDF PubMed Google Scholar), and the been for a number of heterologous expression A.J. Milligan G. Br. J. Pharmacol. 2000; 130: 1825-1832Crossref PubMed Scopus (69) Google Scholar, 13Dunigan C.D. Hoang Q. Curran P.K. Fishman P.H. Biochemistry. 2002; 41: 8019-8030Crossref PubMed Scopus (24) Google Scholar, 14Liang W. Austin S. Hoang Q. Fishman P.H. J. Biol. Chem. 2003; 278: 39773-39781Abstract Full Text Full Text PDF PubMed Scopus (28) Google Scholar). to limited to be an conserved of this GPCR. the been that the cleavage is an in vitro that place during this represents the that the receptor is also in a regulated in vivo. of direct and evidence this the mature hβ1AR with fully processed and was found to be the receptor only as a In pulse-chase labeling the receptor fragments the receptor had been to the mature and receptor transport to the cell surface was with cleavage These results that the receptor is the synthesized receptors have the cell surface or are transported the The of the receptor fragments was by the metalloproteinase inhibitors and to the the had of the N-terminal cleavage by mutation of the cleavage site stabilized mature receptors. The cleavage was enhanced by and that the be by protein kinase C and adenylyl Furthermore, the βAR and were found to the the N-terminal of the fragments with for or not were not the cleavage by the to take place the as the cleavage in vitro during membrane The agonist-mediated of receptor cleavage was both concentration- and time-dependent and was by the is evidence that mature are subject to both and heterologous regulation limited of the N N-terminal cleavage been for a limited number of in the family, for M. T. S. H. J. Biol. Chem. Full Text PDF PubMed Google Scholar, E. J. G. M. R. W. A. J. Biol. Chem. 2002; 277: Full Text Full Text PDF PubMed Scopus Google Scholar) and J. S. A. E. M. J. Biol. Chem. 1996; Full Text Full Text PDF PubMed Scopus Google Scholar, T. R. A. T. Y. J. 2002; PubMed Scopus Google Scholar, L.G. A. F. A. Jr., L. J. Mol. 2007; PubMed Scopus Google Scholar) and for the M.J. K. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar, A. L. A. S. S. A. Full Text Full Text PDF PubMed Scopus Google Scholar), which is the for The the other hand, been to be the between the second transmembrane domain and the extracellular loop E. F. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, E. R. S. F. G. F. J. PubMed Scopus Google Scholar). with the for the hβ1AR, the and receptors are in an agonist binding E. J. G. M. R. W. A. J. Biol. Chem. 2002; 277: Full Text Full Text PDF PubMed Scopus Google Scholar, J. S. A. E. M. J. Biol. Chem. 1996; Full Text Full Text PDF PubMed Scopus Google Scholar, T. R. A. T. Y. J. 2002; PubMed Scopus Google Scholar, E. F. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar), have been for the receptor B. 2004; PubMed Scopus Google Scholar). On the other hand, the cleavage of been to take place protein kinase C activation M.J. K. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar), and it been that matrix metalloproteinase the cleavage and activation of which to and of A. L. A. S. S. A. Full Text Full Text PDF PubMed Scopus Google Scholar). the functional of cleavage have not been fully revealed for other family The of this in distinct of the that regulated cleavage may be a more common than been is the functional of the hβ1AR N-terminal other cell surface transmembrane proteins are known to be in the extracellular domain by the ligand family for example, are synthesized as transmembrane that proteolytic The this way in an or binding to receptors Nat. Rev. Mol. Cell Biol. PubMed Scopus Google Scholar). functional role for the hβ1AR N terminus is as it functional protein is more that the cleavage a role in receptor and signaling in cells. This was by the that the of receptor cleavage by mutation of the cleavage site stabilized mature suggesting that the proteolytic cleavage may have a role in the of cell surface receptors. of the receptor N terminus may the in a that the receptor protein to be in cleavage of the receptor internalization or it the cell surface. and to may be the primary way of of cell surface M. Annu. Rev. Pharmacol. Toxicol. 2008; 48: PubMed Scopus Google Scholar), but it also been e.g. for the β2AR R. S. A. Bouvier M. S. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar), that receptor may occur internalization the cell β1AR ligand-binding site within the 7-transmembrane bundle and in transmembrane and and in the second extracellular loop (18Warne T. Serrano-Vega M.J. Baker J.G. Moukhametzianov R. Edwards P.C. Henderson R. Leslie A.G. Tate C.G. Schertler G.F. Nature. 2008; 454: 486-491Crossref PubMed Scopus (1227) Google Scholar). it is not agonist binding and receptor activation lead to enhanced cleavage of the receptor in the N-terminal be that conformational changes in the transmembrane may be in the N terminus. This may in increase to This is in with that have that cleavage is not the primary structure of the protein but conformational A.J. M. I. Sci. Full Text Full Text PDF PubMed Scopus Google Scholar). by (19Gupta A. Décaillot F.M. Gomes I. Tkalych O. Heimann A.S. Ferro E.S. Devi L.A. J. Biol. Chem. 2007; 282: 5116-5124Abstract Full Text Full Text PDF PubMed Scopus (84) Google Scholar, A. R. Gomes I. Décaillot F.M. Devi L.A. J. Biol. Chem. 2008; Full Text Full Text PDF PubMed Scopus Google Scholar) have that conformational occur in the N terminus of in the family, including the Furthermore, it was also found that an of the receptor was able to changes in the receptor C an that was the C-terminal sites A. R. Gomes I. Décaillot F.M. Devi L.A. J. Biol. Chem. 2008; Full Text Full Text PDF PubMed Scopus Google Scholar). changes in the of β1AR intracellular domains are to conformational changes in the receptor N it be that the increase in the cleavage of the hβ1AR by and may be mediated by the mechanism as binding of the agonist to the receptor. is that the enhanced cleavage of the receptor results functional of the This could occur of the a protein kinase that is activated by the second kinase for example, is known to in to E. A. L. A. Mol. Biol. 2002; PubMed Scopus Google Scholar), a that is for of the protein and its inducible trafficking to the cell surface B. G. J. Cell Sci. PubMed Scopus Google Scholar). These mechanisms that may be for regulated hβ1AR cleavage to be in hβ1AR was found to be modified by both and The was by the that of the N-glycan in the mature receptor in a receptor that more than the receptor of the mature receptor with and revealed that it mucin-type sialylated of a of the for we used the K. A. R. S. 15: PubMed Scopus Google Scholar) to the mucin-type O-glycosylation sites in the receptor N terminus. This O-glycosylation sites for the hβ1AR, and which are well conserved in the hβ1AR, an number of other in the family have been to be modified by These the human M. A. Bouvier M. J. Biol. Chem. 2000; 275: Full Text Full Text PDF PubMed Scopus Google Scholar, J. Biol. Chem. 2008; Full Text Full Text PDF PubMed Scopus Google Scholar), J.G. Biochemistry. 2007; 46: PubMed Scopus Google Scholar), H. M. PubMed Scopus Google Scholar), M. T. R. M. J. H. Full Text Full Text PDF PubMed Scopus Google Scholar, S. M. H. J. J. PubMed Scopus Google Scholar), and S. F. Biochemistry. 2006; PubMed Scopus Google Scholar) as well as and M. T. R. S. T. Y. M. PubMed Scopus Google Scholar). The functional of the nevertheless S. M. H. J. J. PubMed Scopus Google Scholar) found that O-glycosylation to the binding of to the receptor by an of that allow On the other hand, and H. M. PubMed Scopus Google Scholar) showed that the of expression of the receptor its is by the We the the functional role of the O-glycosylation of the hβ1AR, and have to be are is that the O-glycosylation the of the N-terminal domain to metalloproteinases, by the conformational of the N terminus or by of other cell surface proteins, including the have been to the protein proteolytic cleavage J.J. 1994; PubMed Google Scholar). The in the hβ1AR N terminus and are by two proteolytic cleavage sites identified and which for the that may have a IntroductionThe β1-adrenergic receptor (β1AR) 3The abbreviations used are: β1ARβ1-adrenergic receptorhhumanADAMa disintegrin and metalloproteinaseCGP-207121-[2-((3-carbamoyl-4-hydroxy)phenoxy)ethylamino]-3-[4-(1-methyl-4-trifluoromethyl-2-imidazolyl)phenoxy]-2-propanol dihydrochlorideDDMn-dodecyl-β-d-maltosideEndo Hendo-β-N-acetylglucosaminidase HERendoplasmic reticulumGPCRG protein-coupled receptorISOisoproterenolNHSN-hydroxysuccinimidePMAphorbol 12-myristate 13-acetatePNGase Fpeptide-N-glycosidase FBFAbrefeldin A. is one of the three βAR subtypes that are activated by the endogenous catecholamines adrenaline and noradrenaline (1Bylund D.B. Eikenberg D.C. Hieble J.P. Langer S.Z. Lefkowitz R.J. Minneman K.P. Molinoff P.B. Ruffolo Jr., R.R. Trendelenburg U. Pharmacol. Rev. 1994; 46: 121-136PubMed Google Scholar). These receptors belong to the G protein-coupled receptor (GPCR) family, one of the largest membrane protein families involved in cellular signaling (2Fredriksson R. Lagerström M.C. Lundin L.G. Schiöth H.B. Mol. Pharmacol. 2003; 63: 1256-1272Crossref PubMed Scopus (2118) Google Scholar, 3Lagerström M.C. Schiöth H.B. Nat. Rev. Drug Discov. 2008; 7: 339-357Crossref PubMed Scopus (1099) Google Scholar). The β1AR is the predominant βAR subtype in the heart, mediating the increase in cardiac rate and force of contraction (4Rockman H.A. Koch W.J. Lefkowitz R.J. Nature. 2002; 415: 206-212Crossref PubMed Scopus (778) Google Scholar, 5Brodde O.E. Bruck H. Leineweber K. J. Pharmacol. Sci. 2006; 100: 323-337Crossref PubMed Scopus (196) Google Scholar). This makes it the most important target receptor for the β-blockers that are used to treat common cardiac diseases such as chronic heart failure, coronary artery disease, hypertension, and arrhythmias. The mechanisms that regulate human β1AR (hβ1AR) are therefore of considerable interest.The hβ2AR is one of the most extensively studied GPCRs, but much less is known about hβ1AR. The suggestion that it may be more resistant to agonist-mediated desensitization (6Rousseau G. Nantel F. Bouvier M. Mol. Pharmacol. 1996; 49: 752-760PubMed Google Scholar), internalization (7Suzuki T. Nguyen C.T. Nantel F. Bonin H. Valiquette M. Frielle T. Bouvier M. Mol. Pharmacol. 1992; 41: 542-548PubMed Google Scholar, 8Green S.A. Liggett S.B. J. Biol. Chem. 1994; 269: 26215-26219Abstract Full Text PDF PubMed Google Scholar, 9Shiina T. Kawasaki A. Nagao T. Kurose H. J. Biol. Chem. 2000; 275: 29082-29090Abstract Full Text Full Text PDF PubMed Scopus (79) Google Scholar, 10McLean A.J. Milligan G. Br. J. Pharmacol. 2000; 130: 1825-1832Crossref PubMed Scopus (69) Google Scholar, 11Xiang Y. Devic E. Kobilka B. J. Biol. Chem. 2002; 277: 33783-33790Abstract Full Text Full Text PDF PubMed Scopus (89) Google Scholar, 12Liang W. Curran P.K. Hoang Q. Moreland R.T. Fishman P.H. J. Cell Sci. 2004; 117: 723-734Crossref PubMed Scopus (30) Google Scholar), and down-regulation (7Suzuki T. Nguyen C.T. Nantel F. Bonin H. Valiquette M. Frielle T. Bouvier M. Mol. Pharmacol. 1992; 41: 542-548PubMed Google Scholar, 10McLean A.J. Milligan G. Br. J. Pharmacol. 2000; 130: 1825-1832Crossref PubMed Scopus (69) Google Scholar, 13Dunigan C.D. Hoang Q. Curran P.K. Fishman P.H. Biochemistry. 2002; 41: 8019-8030Crossref PubMed Scopus (24) Google Scholar, 14Liang W. Austin S. Hoang Q. Fishman P.H. J. Biol. Chem. 2003; 278: 39773-39781Abstract Full Text Full Text PDF PubMed Scopus (28) Google Scholar) could indicate that the two receptors are regulated by distinct mechanisms. Their ligand-binding sites are well conserved, but the overall homology of the two βARs is only 54% (15Frielle T. Collins S. Daniel K.W. Caron M.G. Lefkowitz R.J. Kobilka B.K. Proc. Natl. Acad. Sci. U.S.A. 1987; 84: 7920-7924Crossref PubMed Scopus (512) Google Scholar). The most diverse regions are the intervening loops that connect the transmembrane domains, the extracellular N terminus and the intracellular C terminus. The third intracellular loops and the C-terminal tails of β1AR and β2AR have been implicated in the mediation of interactions with distinct intracellular proteins, including a number of PSD-95/Discs-large/ZO-1-homology (PDZ) domain-containing proteins that have divergent roles in receptor signaling and trafficking (reviewed in Refs. 16Hall R.A. Semin. Cell Dev. Biol. 2004; 15: 281-288Crossref PubMed Scopus (55) Google Scholar, 17Marchese A. Paing M.M. Temple B.R. Trejo J. Annu. Rev. Pharmacol. Toxicol. 2008; 48: 601-629Crossref PubMed Scopus (350) Google Scholar). In contrast, the extracellular domains of the two βARs have aroused only limited interest and have been thought to have a negligible role in receptor activation and regulation. This is probably related to the relatively short length of the N termini and the absence of noticeable functional domains with conserved motifs as opposed to GPCRs, e.g. in the adhesion receptor family (2Fredriksson R. Lagerström M.C. Lundin L.G. Schiöth H.B. Mol. Pharmacol. 2003; 63: 1256-1272Crossref PubMed Scopus (2118) Google Scholar, 3Lagerström M.C. Schiöth H.B. Nat. Rev. Drug Discov. 2008; 7: 339-357Crossref PubMed Scopus (1099) Google Scholar). Recent evidence nevertheless suggests that the extracellular βAR domains may have a more important role than had been anticipated. For example, the crystal structure of turkey β1AR revealed that the second extracellular loop participates in ligand binding, defining the entrance to the ligand binding pocket within the 7-transmembrane domain bundle (18Warne T. Serrano-Vega M.J. Baker J.G. Moukhametzianov R. Edwards P.C. Henderson R. Leslie A.G. Tate C.G. Schertler G.F. Nature. 2008; 454: 486-491Crossref PubMed Scopus (1227) Google Scholar). On the other hand, ligand binding was found to lead to conformational changes in the β2AR N terminus and extracellular loops, as was revealed by conformation-specific antibodies and NMR spectroscopy, respectively (19Gupta A. Décaillot F.M. Gomes I. Tkalych O. Heimann A.S. Ferro E.S. Devi L.A. J. Biol. Chem. 2007; 282: 5116-5124Abstract Full Text Full Text PDF PubMed Scopus (84) Google Scholar, 20Bokoch M.P. Zou Y. Rasmussen S.G. Liu C.W. Nygaard R. Rosenbaum D.M. Fung J.J. Choi H.J. Thian F.S. Kobilka T.S. Puglisi J.D. Weis W.I. Pardo L. Prosser R.S. Mueller L. Kobilka B.K. Nature. 2010; 463: 108-112Crossref PubMed Scopus (397) Google Scholar).To initiate investigations into the mechanisms that regulate hβ1AR, we set out to characterize the specific steps that take place during the biogenesis of this GPCR. We demonstrate here that the receptor N terminus is extensively modified by mucin-type O-glycosylation during the rapid transport to the cell surface in addition to one N-glycan. Furthermore, the N terminus of the mature receptor with fully processed oligosaccharides was found to be subject to proteolytic cleavage by metalloproteinases, a cleavage that occurred both in vitro and in vivo. This cleavage was enhanced by agonist-mediated receptor activation and by direct activation of protein kinase C and adenylyl cyclase. On the other hand, mutation of the primary cleavage site was found to lead to stabilization of mature receptors. These results allow us to hypothesize that the N-terminal cleavage represents a novel way of controlling the number of functionally active cell surface β1ARs.
52
Structure of a β1-adrenergic G-protein-coupled receptor
Tony Warne, María J. Serrano‐Vega, Jillian G. Baker et al. · Nature · 2008 · 1.3K citations · Full text
Adrienne Boire, Lidija Covic, Anika Agarwal et al. · Cell · 2005 · 840 citations · Full text
Medicine, Cancer Biology, Oncology +13
Tyrosine Sulfation of the Amino Terminus of CCR5 Facilitates HIV-1 Entry
Michael Farzan, Tajib A. Mirzabekov, Peter Kolchinsky et al. · Cell · 1999 · 698 citations · Full text